BiotechTube
Ardigen

Ardigen

Krakow, Poland· Est.
ardigen.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $6.5M

Overview

Ardigen is a leading AI-driven CRO that accelerates and de-risks drug discovery and development for biotech and pharmaceutical partners. The company combines multidisciplinary expertise in molecular biology, bioinformatics, data science, and software engineering to deliver end-to-end solutions, from target identification to clinical trial optimization. With a proven track record of aiding over 15 drug programs and a strong client base, Ardigen positions itself as a strategic partner for integrating advanced AI into the R&D pipeline.

AI / Machine Learning

Technology Platform

Integrated AI and bioinformatics platform covering Data Universe (multi-omics, biobank access), AI/ML solutions for target ID, molecule design (small molecules & biologics), phenotypic profiling, and clinical trial optimization. Includes Generative AI, LLMs for biology, custom software engineering, and ML infrastructure (AI Workbench, ML Ops).

Funding History

2
Total raised:$6.5M
Series A$5M
Seed$1.5M

Opportunities

The growing pressure on pharma R&D productivity and the explosion of complex biomedical data create a massive market for AI-driven drug discovery services.
Ardigen can capitalize on trends in generative AI and foundational models for biology to offer increasingly powerful and differentiated solutions, potentially expanding into more scalable software platform offerings.

Risk Factors

Intense competition from other AI CROs and platform companies, reliance on project-based revenue which can be volatile, and the ongoing challenge of accessing, integrating, and deriving value from disparate and sensitive biomedical data sources.

Competitive Landscape

Ardigen competes in the AI-powered drug discovery services space against large CROs (e.g., IQVIA, Labcorp) building AI capabilities, pure-play AI biotech firms (e.g., Exscientia, Recursion) that may also offer partnerships, and other specialized AI/ML bioinformatics service providers. Its differentiation lies in its deep multidisciplinary integration and end-to-end service model from data to deployable software.

More companies in AI / Machine Learning →More companies in Poland →